MEDICINE
39 articole · RSS
Antibiotice Iasi Invests EUR75M In Production Of Critical Medicines
State-run Antibiotice Iasi (ATB.RO), has started a EUR75 million strategic project to build a research and development center and a new production facility for critical medicines.
Romanians Spent RON21B on Medicines in 2021
The pharmaceutical market in Romania generated sales of over RON21 billion in 2021, up 17% from the previous year, according to data provided by market research company Cegedim.
Romanians Spend RON700M On Cold and Flu Medicine A Year
Sales of over the counter cold and flu drugs rose by 20% in pharmacies in January, after the authorities announced a national flu epidemic.
Generics Makers Say Rising Clawback Tax Drives Local Industry Out of Business
Thousands of generic medicines will vanish from the Romanian market as the clawback increased 25% in the third quarter and will drive the local pharmaceutical industry out of business, the R...
Drugmaker Sintofarm Wants To Become Real Estate Company
Shareholders of drugmaker Sintofarm (SINT.RO) will meet on December 21 to decide on the sale of equipment, brands and other assets except for buildings, and on renaming the company Imosint a...
Medicine Sales In Romania Down 10% To RON2.74B In 3Q
Medicine sales in Romania fell 9.9% on the year to RON2.74 billion in the third quarter, considering distribution prices, following the price cut of prescription drugs, according to Cegedim'...
Medicine Sales In Romania Down 4.1% To RON2.83B In 2Q
Medicine sales in Romania fell 4.1% on the year to RON2.83 billion in the second quarter, considering distribution prices, according to Cegedim's Pharma & Hospital Report.
Drugmakers May Give Up Investments In 2014 On Clawback Tax Hike
Drugmakers operating in Romania will have to cease investments in 2014 and give up unprofitable products due to the 30% increase of the clawback tax in the fourth quarter of 2013, Dragos Dam...
Zentiva To Boost Exports To 50% Of Production
The exports of Sanofi Romania’s Zentiva plant in Bucharest have reached 14% of its production, from 8% last year, says Christophe Gourlet, the general manager of the company.